An overview of adenosine A2A receptor antagonists in Parkinson's disease

P Jenner - International review of neurobiology, 2014 - Elsevier
Adenosine A 2A receptor antagonists represent a new way forward in the symptomatic
treatment of Parkinson's disease (PD) through a non-dopaminergic mechanism. As a class …
被引用次数：96 相关文章

An Overview of Adenosine A2A Receptor Antagonists in Parkinson's Disease

P Jenner - Adenosine Receptors in Neurology and Psychiatry, 2014 - books.google.com
Adenosine A2A receptor antagonists represent a new way forward in the symptomatic
treatment of Parkinson's disease (PD) through a non-dopaminergic mechanism. As a class …

An Overview of adenosine A2A receptor antagonists in Parkinson's disease

P Jenner - International Review of Neurobiology, 2014 - kclpure.kcl.ac.uk
Adenosine A 2A receptor antagonists represent a new way forward in the symptomatic
treatment of Parkinson's disease (PD) through a non-dopaminergic mechanism. As a class …

An overview of adenosine A2A receptor antagonists in Parkinson's disease

P Jenner - International review of neurobiology, 2014 - pubmed.ncbi.nlm.nih.gov
Adenosine A2A receptor antagonists represent a new way forward in the symptomatic
treatment of Parkinson's disease (PD) through a non-dopaminergic mechanism. As a class …

An overview of adenosine A2A receptor antagonists in Parkinson's disease.

P Jenner - International Review of Neurobiology, 2014 - europepmc.org
Adenosine A2A receptor antagonists represent a new way forward in the symptomatic
treatment of Parkinson's disease (PD) through a non-dopaminergic mechanism. As a class …